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Abstract
The accessory protein, PB1-F2, of influenza A virus (IAV) functions in a chicken host to prolong infectious virus shedding and
thus the transmission window. Here we show that this delay in virus clearance by PB1-F2 in chickens is accompanied by
reduced transcript levels of type 1 interferon (IFN)-induced genes and NFkB-activated pro-inflammation cytokines. In vitro,
two avian influenza isolate-derived PB1-F2 proteins, H9N2 UDL01 and H5N1 5092, exhibited the same antagonism of the IFN
and pro-inflammation induction pathways seen in vivo, but to different extents. The two PB1-F2 proteins had different
cellular localization in chicken cells, with H5N1 5092 being predominantly mitochondrial-associated and H9N2 UDL being
cytoplasmic but not mitochondrial-localized. We hypothesized that PB1-F2 localization might influence the functionality of the
protein during infection and that the protein sequence could alter cellular localization. We demonstrated that the sequence of
the C-terminus of PB1-F2 determined cytoplasmic localization in chicken cells and this was linked with protein instability.
Mitochondrial localization of PB1-F2 resulted in reduced antagonism of an NFkB-dependent promoter. In parallel,
mitochondrial localization of PB1-F2 increased the potency of chicken IFN 2 induction antagonism. We suggest that
mitochondrial localization of PB1-F2 restricts interaction with cytoplasmic-located IKKb, reducing NFkB-responsive promoter
antagonism, but enhances antagonism of the IFN2 promoter through interaction with the mitochondrial adaptor MAVS. Our
study highlights the differential mechanisms by which IAV PB1-F2 protein can dampen the avian host innate signalling
response.
INTRODUCTION
Influenza A viruses (IAVs) are respiratory pathogens of
multiple species, including poultry and humans. The high
prevalence levels of IAV infection in poultry in the Middle
East and South-East Asia, where it is considered to be
endemic in some countries, are a significant economic bur-
den to the poultry industry [1, 2]. It is estimated that the
H7N9 subtype of avian IAV caused upwards of $6.5 billion
in losses to the Chinese economy in 2013 alone [3]. Food
security, animal welfare and of course the potential spillover
into the human population and the resulting possibility of
pandemics, are all important reasons for further study of
IAV interactions within avian hosts, with the aim of
enabling the design and implementation of better control
strategies for IAV in poultry.
IAVs have a core repertoire of 10 viral proteins that all sub-
types express, allowing successful replication of the virus in
infected cells. There is also an ever increasing number of
‘accessory’ proteins that are not required for replication in a
cell, but which contribute and modulate IAV infection in
vivo [4]. In 2001, PB1-F2 was the first accessory protein to
be identified in IAV [5]. PB1-F2 is a small protein that
ranges in size from 87 to 101 amino acids (aa) and is
expressed from genome segment 2 of IAV in a +1 reading
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frame relative to that of the PB1 protein, the viral RNA-
dependent RNA polymerase [5]. The presence of PB1-F2 in
the IAV genome is highly conserved (93%) as a full-length
protein in IAV isolates recovered from avian species, which
contrasts with a full-length conservation of only 43% in
human- or 48% in swine-isolated IAV sequences [6, 7].
Many functions have been attributed to PB1-F2 since its
identification; it has variously been shown to induce apo-
ptosis, antagonize innate immune responses, promote sec-
ondary bacterial infection and modulate viral polymerase
activity, but many of these functions have been shown to be
cell type- and IAV strain-dependent [8, 9]. It has also been
shown to be rapidly turned over in cells due to degradation
by the proteosome [10].
Previously we and others have shown that the absence of a
full-length PB1-F2 protein in an avian IAV has the effect of
increasing pathogenicity in chickens, in both highly patho-
genic and low-pathogenic IAV infection models [6, 11]. It
has been documented in mammalian models that IAV
infections with large innate responses, characterized by
extraordinary levels of inflammatory cytokines and chemo-
kines, correlate with enhanced pathogenicity [12, 13].
Therefore the absence of PB1-F2 resulting in enhanced
innate immune responses is a likely mechanism for this
increase in pathogenicity in chickens. It has previously been
demonstrated in mammalian cells infected with IAV that
PB1-F2 can antagonize anti-viral innate responses, for
example Yoshizumi et al. and others report that human
interferon beta (IFNb) promoter activation is suppressed by
the presence of PB1-F2 [14–17]. Additionally, in vivo, in
mice, type 1 interferon (IFN)-induced transcripts in the
lung were reduced when PB1-F2 was present [18]. In chick-
ens, in the context of a highly pathogenic H5N1 IAV, it was
found that similar to mice, infection with a virus that con-
tained a full-length PB1-F2 protein resulted in reduced lev-
els of a range of anti-viral innate gene transcripts [11]. A
direct interaction between PB1-F2 of the vaccine strain A/
PR/8/34 (PR8) and human mitochondrial antiviral signal-
ling protein (MAVS) has been demonstrated by co-immu-
noprecipitation and it is thought that PB1-F2 exerts its
antagonist function of mammalian IFNa/b through modu-
lation of this critical adapter protein in the IFN induction
pathway [19, 20]. Reis et al. showed that PB1-F2 from a
range of avian IAVs and PR8 was able to interact with
human IKKb, resulting in the inhibition of human NFkB
activation [18]. The antagonistic functionality of PB1-F2 for
the interferon-induced and pro-inflammation pathways in
avian cell lines and hosts is less clear, however, with only
one study providing data where the effect of PB1-F2 on
transcript levels of interferon-stimulated genes in the lungs
of chickens infected with a highly pathogenic H5N1 strain
was analysed [11]. Leymarie et al. showed that transcripts of
the interferon signalling pathway were downregulated when
they compared datasets from infections by a PB1-F2-con-
taining virus and the isogenic knock-out of PB1-F2. Differ-
ences exist between the signalling induction pathways for
innate response cytokines and chemokines in chickens and
mammals; for example, chickens lack the pattern recogni-
tion receptor RIG-I, which is important for initiating the
type 1 IFN induction pathway in mammals [21]. Sequence
comparison between human MAVS and chicken MAVS
shows only a 39% conservation at the amino acid level,
whereas there is a stronger degree of conservation between
human IKKb and that in the chicken genome (83% conser-
vation at amino acid level). There has been no analysis of
the mechanism of immune response suppression in the
chicken host by PB1-F2. It is likely that host immune
response suppression results in the observation that our
group previously reported, that the presence of a PB1-F2
protein in a low pathogenic H9N2 IAV can prolong the
virus shedding duration in chickens, resulting in an
increased transmission window and environmental contam-
ination [6].
In mammalian cells, PB1-F2 proteins display one of two
sub-cellular localizations; predominantly mitochondrial-
associated, as is the case for the PB1-F2 protein from the
laboratory-adapted H1N1 A/PR8/8/34 (PR8), or diffuse in
the cytoplasm, with a small proportion of mitochondrial
localization, as is the case for H5N1 A/HK/156/1997 [5, 22–
25]. However, no study of cellular localization in avian cell
types has been undertaken. It has been noted in several
reports that the C-terminus sequence of the PB1-F2 protein
determines cellular localization in mammalian cells,
although the residues that confer mitochondrial targeting
appear to vary between PB1-F2 proteins [22]. The ability of
PB1-F2 to antagonize mammalian IFNa/ b promoters has
been linked to the C-terminus of PB1-F2 [19, 20].
The PB1-F2 protein of IAV is variable in sequence, which
has been shown to impact on cellular localization and func-
tion in mammalian cells. There is a paucity of published
information about PB1-F2 in the context of IAV infection
of avian cells and IAV isolates that infect avian species are
more likely to have a full-length PB1-F2 protein encoded in
their genome. Therefore there is a particular gap in our
knowledge of the specific in vitro functions of PB1-F2 in
avian cells and how these might be correlated with the
effects of PB1-F2 on IAV pathogenicity and viral shedding
in chickens.
Here we analysed the cellular localization and ability of
avian IAV PB1-F2 proteins to antagonize type 1 IFN
(chicken IFN-1 and IFN-2) and pro-inflammation induc-
tion pathways in chicken cells. We demonstrated that the
C-terminal sequence of PB1-F2 can alter the cellular locali-
zation and that mitochondrial association of PB1-F2 affects
the antagonistic function and stability of PB1-F2 in chicken
cells. We confirmed interactions with chicken orthologues
of MAVs and IKKb, suggesting that PB1-F2 acts to suppress
innate responses in chickens and this is the mechanism of
suppressed pathogenicity and prolonged viral shedding of
IAV strains that carry full-length PB1-F2 proteins.
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Fig. 1. PB1-F2 protein from avian influenza viruses have different subcellular locations in chicken cells. PB1-F2 proteins from a range
of avian influenza subtypes were cloned into expression plasmids. DF-1 cells were transfected with V5-PB1-F2 expression plasmids
and 12 h post-transfection stained with MitoTracker Red CMXRos [mitochondria (red)]. The cells were subsequently fixed and immu-
nostained with an anti-V5 antibody [PB1-F2 (green)] and the nuclei were stained with DAPI [nucleus (Blue)]. Lines were drawn trans-
ecting objects in the ‘red’ channel (displayed as white lines) and the pixel intensities along these transects for both the ‘red’ and ‘green’
channels were displayed graphically. Pearson’s correlation coefficients for of transects were calculated and the R2 values were dis-
played. Displayed are representatives of these lines, which were drawn randomly at three locations per image.
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RESULTS
PB1-F2 proteins from different strains of avian
influenza virus have distinct cellular localizations
in chicken cells
We analysed the association with mitochondria of PB1-
F2, from a wide panel of different avian influenza virus
subtypes (Table 1), in a chicken fibroblast cell line
(Fig. 1). DF1 cells were transfected with plasmids
encoding PB1-F2 proteins with an N-terminal V5 tag
and immune-stained for the V5 tag along with Mito-
tracker dye to highlight the mitochondria before imag-
ing by confocal microscopy. Co-localization between
mitochondria and PB1-F2 was quantified by drawing
transects through the mitochondria and determining
the correlation of pixel intensity for PB1-F2 and mito-
chondrial staining using Pearson’s coefficient. Both
visually and by quantification, the PB1-F2 proteins
could be categorized into two groups; those with strong
mitochondrial co-localization, with Pearson’s coefficients
of >0.7 (H5N1 50–92, H3N8a and H10N7), and those
that showed a diffuse cytoplasmic localization with a
weak mitochondria association, with Pearson’s coeffi-
cients of <0.7 (H9N2 UDL01, H8N4, H11N9, H3N8b
and H6N2).
Localization of PB1-F2 in the cytoplasm is
determined by amino acids in the C-terminus of the
protein
The PB1-F2 proteins of the viruses H9N2 UDL01 and
H5N1 50–92 are examples that fell into the two differ-
ent localization patterns. H9N2 UDL01, R2=0.243
[±0.032 standard error of the mean SEM)], is predomi-
nantly cytoplasmic, whereas H5N1 50–92, R2=0.749
(±0.024 SEM), is predominantly mitochondria-associated
(Figs 1 and 2b). A comparison of the primary amino
acid sequences of H9N2 UDL01 and H5N1 50–92
PB1-F2 proteins revealed that there were 11 amino
acid differences between them, 4 in the N-terminal
region (aa 1–35) and seven in the C-terminus (aa 41–
90) (Fig. 2a). Previous reports have demonstrated that
the association of PB1-F2 with mitochondria in mam-
malian cells is determined by the PB1-F2 C-terminus
[14, 22, 23]. Therefore we generated chimeric PB1-F2
proteins, whereby a swap of the C-terminus (aa 41–90)
was made. We generated UDL01 : 5092 PB1-F2, which
contained the N-terminus of H9N2 UDL01 and the C-
terminus of H5N1 50–92, and the reciprocal swap
5092:UDL01 PB1-F2 (Fig. 2a). Transects drawn through
mitochondria on confocal microscopy images confirmed
that V5-PB1-F2 localization to the cytoplasm was
determined by the C-terminus of the UDL01 PB1-F2
protein (Fig. 2b). However, the H5N1 5092 C-terminus
(UDL01 : 5092) did not enable localization at the mito-
chondria to the same extent as the H5N1 5092 WT
PB1-F2. The UDL01 : 5092 PB1-F2 protein was, how-
ever, more efficiently targeted to the mitochondria,
with a mean R2 correlation value of 0.648 (±0.026 SEM),
than 5092:UDL01, which was predominantly cyto-
plasmic, with the mean R2 correlation value with mito-
chondria being 0.273 (±0.045 SEM) (Fig. 2b). Previous
publications have demonstrated that putative mitochon-
drial targeting sequences lie between amino acid resi-
dues 46 and 75. There were four residues that were
different between our two prototypic strains in this aa
46–75 region, so we generated expression constructs
that swapped all four mutations in both the H9N2
UDL01 and H5N1 5092 PB1-F2 proteins to analyse in
greater detail those residues that contribute to PB1-F2
localization away from the mitochondria. Site-directed
mutagenesis at aa 60, 62, 66 and 68 (from R, H, N
and I respectively) in H9N2 UDL01 to Q, L, S and T,
as is the sequence in H5N1 5092, generated the
UDL01-4M PB1-F2 and the reverse mutations in
H5N1 5092 generated the 5092–4M PB1-F2. Co-locali-
zation of UDL01-4M and 5092–4M PB1-F2 proteins
that were V5-tagged with mitochondria via co-staining
with Mitotraker Red in DF-1 cells demonstrated that
the 5092–4M PB1-F2 was relocalized in a diffuse pat-
tern to the cytoplasm (R2=0.399) (Fig. 2c), similarly to
UDL WT [R2=0.024 (±0.032 SEM)] and 5092:UDL01 [R2
=0.273 (±0.045 SEM)]. Conversely, UDL01-4M PB1-F2
had no effect on mitochondrial localization (R2=0.265)
(Fig. 2c), maintaining a similar diffuse cytoplasmic
localization to H9N2 UDL, in contrast to the UDL01 :
5092 mutant [R2=0.647 (±0.045 SEM)]. This suggests
that mitochondrial targeting is more easily disrupted
than the retargeting of PB1-F2 to the mitochondria,
which may require features in the full-length protein.
Sequence analysis of the region between aa 46–75 of
the other avian influenza virus PB1-F2 proteins from
Fig. 1 indicated that the four amino acids identified as
being important for the cytoplasmic localization of the
H5N1 5092–4M PB1-F2 are not common in cyto-
plasmic-targeted PB1-F2s. Indeed, the PB1-F2 protein
from H8N4 A/Mallard/Alberta/192/92 had a cyto-
plasmic localization and shared identical residues at
these four positions with H5N1 5092, which was mito-
chondrial-targeted. None of the other PB1-F2 proteins
Table 1. Subtypes of avian influenza virus from which the PB1-F2
proteins were extracted for study
Virus short
name
Viral strain Length of PB1-F2 protein
(aa)
H3N8a A/mallard/Alb/156/2001 90
H3N8b A/duck/Italy/3139/V06 90
H5N1 5092 A/Turkey/England/5092/
91
90
H6N2 A/duck/Italy/2253/V06 90
H8N4 A/mallard/Alb/194/92 90
H9N2 UDL01 A/chicken/Pakistan/
UDL01/08
90
H10N7 A/duck/Italy/1398/V06 90
H11N9 A/duck/Italy/6103/V07 90
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shared the 60R, 62 h, 66N, 68I motif seen in H9N2
UDL01, although the mitochondrial-located PR8 PB1-F2
has 60R, 66N, 68I (Fig. 2d).
PB1-F2 suppresses interferon-stimulated gene
transcripts upon avian influenza virus infection in
chicken cells
To provide robust data on the functionality of PB1-F2 to
antagonize the type I interferon signalling pathway in chick-
ens we used several different methods. Firstly, we analysed
and compared the transcript levels of ISGs in nasal tissue
taken from chickens at 2 and 5 days post-infection with iso-
genic H9N2 viruses that contain the coding capacity for
either a full-length PB1-F2 protein (H9N2 UDL01) or a
truncation to the initial 11 aa of PB1-F2 (H9N2 UDL01-
KO), deemed to be non-functional and therefore a knock-
out (Fig. 3a). These two viruses had previously been
reported on in James et al. and replicated in chicken tissues
to similar levels on day 2 post-infection but with the PB1-F2
knock-out H9N2 infectious virus being cleared more
quickly on day 5 than the H9N2 with a full-length PB1-F2
protein (Fig. S1) [6]. We observed significantly increased
transcript levels for several ISGs and cytokines in the nasal
tissue from birds infected by the H9N2 PB1-F2 knock-out
virus on both day 2 (Mx, OAS, STAT-1 and IL-6) and day 5
(Mx, IL-6 and IL-1b) post-infection (Fig. 3a).
We utilized primary chicken embryonic fibroblast (CEF)
cells and chicken bone marrow-derived monocyte (BMDM)
cells to see whether the same upregulation of ISG and cyto-
kine transcripts was observed in vitro by avian influenza
viruses lacking a functional PB1-F2 protein compared to
Fig. 2. PB1-F2 protein localization to the mitochondria in chicken cells was mapped to residues in the C-terminus of PB1-F2. (a) Sche-
matic of the amino acid differences between H5N1 5092 (red) and H9N2 UDL01 (blue) PB1-F2 proteins. Chimeric proteins were con-
structed that had the entire C-terminal portions (5092:UDL01 and UDL01 : 5092) or four residues (60, 62, 66 and 68; 5092–4M and
UDL01-4M) swapped between the H5N1 5092 and H9N2 UDL01 strains. (b) and (c) DF-1 cells were transfected with the wild-type V5-
PB1-F2 proteins or the V5-PB1-F2 chimeras and stained to indicate the co-localization between V5-PB1-F2 (green) and mitochondria
(red). Nuclear staining is indicated by DAPI staining (blue). Transects (white lines) drawn in both the mitochondria and PB1-F2 channel
were compared via Pearson’s correlation coefficient. In (b) the Pearson’s correlation coefficient (R2) values from 10 cells for each PB1-
F2 construct were averaged and plotted. One-way analysis of variance (ANOVA) was used to determine whether significant differences
in the correlations existed. ****, P<0.0005; NS, not significant. (d) The C-terminal sequences (aa 45–90) of the PB1-F2 proteins analysed
in Fig. 1, in addition to the well-characterized H1N1 (A/PR/8/34) and H5N1 (A/HK/196/97), were aligned. Differences at the 4M muta-
tions (aa 60, 62, 66 and 68) are highlighted, as is mitochondrial localization (mitochondrial=Y, cytoplasmic=N) and the number of leu-
cine residues in the C-terminal fragment (leucines).
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those possessing a full-length PB1-F2 protein (Fig. 3b, c). In
both cell types, the H5N1 5092 virus pair (H5N1 5092 and
H5N1 5092-KO) showed a significant increase in Mx and
OAS transcript levels when PB1-F2 was absent during
infection and the trend was evident for the H9N2 UDL01
virus pair, although it was not statistically significant. In the
BMDM, the transcript levels for IL-6 and IL-8 were signifi-
cantly elevated when PB1-F2 was absent in the H9N2
Fig. 3. In vivo and in vitro, PB1-F2 suppresses chicken interferon-stimulated gene and pro-inflammatory gene transcripts. Total RNA
was isolated from the chicken substrates detailed. The RNA was reverse transcribed and used to quantify chicken host response
genes via qPCR. Ct values were compared to those of the reference gene RPLPO1 and quantified using the DDCt method of quantifica-
tion. The means +/ SD are shown. Multiple Student’s t-tests were performed to compare between wild-type and knock-out means and
the Holm–Sidak correction for multiple comparisons was applied. *, P0.05; **, P0.01. (a) Nasal tissue taken from six chickens
infected with influenza virus possessing a full-length PB1-F2 protein (H9N2 UDL01) or a point mutation abrogating PB1-F2 expression
(H9N2 UDL01 KO) at day 2 or day 5 post-infection. (b) Primary chicken embryonic fibroblast (CEF) cells or (c) chicken bone marrow-
derived macrophage (BMDM) cells infected with a multiplicity of infection (m.o.i.) of 3 of H9N2 UDL01 or H5N1 5092 viruses that have
a full-length PB1-F2 or a knock-out PB1-F2 (KO). At 8 h post-infection, cells were lysedfor RNA isolation, this was repeated in three
independent experiments. Supernatants from CEF cells (d) or from chicken BMDM cells (e) infected with H9N2 UDL01 or H5N1 5092
viruses that had a full-length PB1-F2 or a knock-out PB1-F2 (KO) were incubated on Madin–Darby canine kidney (MDCK) cells for 12 h
and assayed for the presence of IAV nucleoprotein (NP) with a mouse anti-NP antibody and anti-mouse IRDye 800CW antibody (LI-COR)
before being visualized by the Odyssey Imaging System (LI-COR).
James et al., Journal of General Virology
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UDL01-KO virus and again this trend was evident for the
H5N1 5092 virus pair, but it was not statistically significant.
The H9N2 UDL01 and H5N1 5092 virus pairs were equally
able to infect both CEFs and BMDMs at a multiplicity of
infection (m.o.i.) of 3 (Fig. 3d, e). The growth curves of the
virus pairs in primary chicken kidney cells (Fig. S4a)
showed that for both pairs of viruses there was no difference
in infectious virus release at early time points post-infection,
up to 24 h. We did observe significantly more virus at 48 h
post-infection in the growth curve for the H5N1 5092 PB1-
F2 KO virus compared to H5N1 5092 WT. In the chicken
fibroblast DF-1 cell line, the reconstituted viral polymerase
activity of both the H5N1 5092 and H9N2 UDL01 viruses
was not affected by the ability of the PB1 segment to encode
a full-length PB1-F2 (Fig. S4b). Our in vitro infections sug-
gested that the PB1-F2 of both H9N2 UDL01 and H5N1
5092 was able to suppress ISG and pro-inflammation cyto-
kines transcripts, but the potency of the antagonism varied.
There was a trend in the in vitro-tested substrates, CEFs and
chicken BMDM for the PB1-F2 of H5N1 5092 to be able to
antagonize chicken IFN1- and IFN2-stimulated genes, Mx
and OAS more potently upon infection (a difference of 50–
250-fold compared to H5N1 5092-KO), whereas the H9N2
UDL01 PB1-F2 displayed a more modest 20-fold difference
compared with H9N2 UDL01-KO. In contrast, the H9N2
UDL01 PB1-F2 antagonized the pro-inflammation cyto-
kines IL-6 and IL-8 more potently than H5N1 5092 PB1-F2
upon infection (Fig. S3 b-c).
Co-localization with the mitochondria and
consequently MAVS enhances chicken IFN-2
promoter antagonism by PB1-F2
We performed a co-localization study in chicken DF-1 cells
by overexpression of a V5-tagged chicken MAVS construct
(ckMAVS-V5) and a FLAG-tagged version of the H9N2
UDL01 and H5N1 5092 PB1-F2 proteins (Figs 4a and S2).
Similarly to the co-localization with Mitotraker, we per-
formed immune staining against the FLAG and V5 tags and
drew transect lines through the confocal images along the
ckMAVS-V5 staining and the correlation of pixel intensity
along these transects for each stain was then calculated
using Pearson’s coefficient. We observed that mitochon-
drial-targeted H5N1 5092 PB1-F2 protein had a strong co-
localization with ckMAVS (R2=0.851±0.022 SEM), whereas
the H9N2 UDL01 PB1-F2 protein only had a weak correla-
tion (R2=0.332±0.042 SEM); a GFP-FLAG expression con-
struct was used as a control and showed no co-localization
with ckMAVS-V5 (R2= 0.002±0.020 SEM) (Fig. 4a). Co-
immunoprecipitation using an anti-V5 antibody from DF-1
cells expressing ckMAVS-V5 and either FLAG-tagged
H5N1 5092 or H9N2 UDL01 PB1-F2 demonstrated that
both PB1-F2 proteins could interact with ckMAVS, but that
the efficiency of the binding differed, with the H5N1 5092
PB1-F2 associating to a greater extent with ckMAVS than
H9N2 UDL01 (Fig. 4b).
Having already detailed the cellular localization difference
of the PB1-F2 proteins, H9N2 UDL01 and H5N1 5092, we
hypothesized that cellular localization could influence the
potency with which type 1 IFN was induced and conse-
quently ISGs during infection. Therefore we used a well-
described IFN bioassay that makes use of type 1 IFN inhibi-
tion of a GFP vesicular stomatitis virus (VSV-GFP) to deter-
mine the ability of the PB1-F2 proteins to antagonize the
production of bioactive chicken IFN from DF-1 chicken
cells [26]. We applied equal volumes of virus-inactivated
supernatant taken from chicken BMDM cells infected with
H9N2 UDL01 and H5N1 5092 isogenic virus pairs that con-
tained a full-length PB1-F2 or PB1-F2 KO, at a high m.o.i.
to DF-1 cells, as a primer, prior to infection of the DF-1s by
VSV-GFP. The level of GFP fluorescence measured in the
cells was therefore inversely proportional to the relative lev-
els of IFNs secreted during the initial influenza infection.
We found that in both virus pairs the parental viruses that
contained a full-length PB1-F2 protein induced less type 1
IFN following infection than the viruses that were knocked
out for PB1-F2 (Fig. 4c). This suggested that the level of IFN
induction was suppressed more by the PB1-F2 from H5N1
5092, which is located predominantly at the mitochondria,
co-localized with ckMAVS, than the PB1-F2 from H9N2
UDL01, which has a more modest co-localization with
MAVS and a predominantly cytoplasmic cellular
localization.
To increase the clarity of the relationship between subcellu-
lar localization of PB1-F2 and the antagonism of IFN and
the subsequently induced ISGs, we utilized a chicken IFN-2
promoter firefly luciferase reporter construct in DF-1 cells.
The reporter was co-transfected with poly I : C, which can
induce the IFN- 2 promoter, a constitutively expressed
Renilla reporter and PB1-F2 plasmids. We compared the
ability of H5N1 5092 PB1-F2 with that of H9N2 UDL01
PB1-F2 and found that, in line with our other results, H5N1
5092 PB1-F2 was more potent in the antagonism of the
chicken IFN- 2 promoter (Fig. 4d). In conjunction, we uti-
lized the chimeric PB1-F2 proteins containing the reciprocal
C-terminus swaps, 5092:UDL01 and UDL01 : 5092, which
show altered cellular localizations with respect to the mito-
chondria, compared to the parental PB1-F2 proteins. Our
results demonstrated that possession of the H9N2 UDL01
C-terminus, which disrupted mitochondrial localization,
resulted in a reduced antagonism of the chicken IFN-2 pro-
moter compared to those PB1-F2 proteins containing the
H5N1 5092 C-terminus (Fig. 4d).
Co-localization with the mitochondria did not
correlate with enhanced PB1-F2 antagonism of an
NFkB responsive promoter
Influenza virus infection is known to activate NFkB tran-
scription of cytokines involved in inflammation, such as IL-
8 and IL-1b. In chickens infected by a H9N2 virus that pos-
sessed a full-length PB1-F2 protein, some of the transcripts
for pro-inflammatory genes, e.g. IL-6 and IL-1b, were
supressed compared to infection where the PB1-F2 was
absent (Fig. 3a). To determine whether PB1-F2 from the
avian influenza strains H9N2 UDL01 and H5N1 5092
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specifically antagonized NFkB activation, we utilized a
NFkB response element luciferase reporter construct in
chicken DF-1 cells, and this was co-transfected with a con-
stitutively active Renilla luciferase plasmid and PB1-F2 plas-
mids. Cells were stimulated by transfection with poly (poly
I : C), which activated NFkB, leading to luciferase induction.
Co-expression of H9N2 UDL01 PB1-F2 significantly inhib-
ited the luciferase signal, whereas co-expression of H5N1
5092 PB1-F2 did not, although there was a trend in multiple
assays for the luciferase signal to be lower than for no PB1-
F2 expression (empty) (Fig. 5a). H9N2 UDL01 PB1-F2 inhi-
bition of the NFkB response element was due to the inhibi-
tion of NFkB nuclear translocation (Fig. S3).
We utilized our C-terminus-swapped PB1-F2 constructs to
determine the contribution of the C-terminus sequence, and
by inference cellular localization, to the ability of PB1-F2 to
antagonize NFkB activity. We found that both 5092:UDL01
and UDL01 : 5092 PB1-F2 proteins were able to significantly
inhibit NFkB-responsive promoter activity in this set-up
(Fig. 5a). UDL01 : 5092 was only partially mitochondrial-
Fig. 4. Co-localization of PB1-F2 with mitochondria increases the antagonism of the IFN2 promoter. (a) DF-1 cells were transfected
with over-expression plasmids for the wild-type FLAG-tagged PB1-F2 proteins or eGFP and chicken MAVS-V5. Transects were drawn
in both the MAVS and PB1-F2/eGFP channel and co-localization via pixel intensity was compared using Pearson’s correlation coeffi-
cient. Pearson’s correlation coefficient (R2) values from 10 cells for each PB1-F2 construct and eGFP were averaged and plotted. One-
way ANOVA was used to determine whether significant differences in the correlations existed. ****, P<0.0005. (b) DF1 cells were co-
transfected with PB1-F2-FLAG and chicken MAVS–V5 expression constructs in varying combinations, as shown. The input expression
levels of PB1-F2 and ckMAVS plus the resultant co-immunoprecipitation pulled down proteins on protein G beads by an anti-V5 anti-
body. This image is representative of the experiment, which was performed twice. (c) UV-inactivated cell supernatants from high-m.o.i.
influenza virus infections of BMDMs were serially diluted (log2) and incubated on DF-1 cells for 12 h. Cells were washed and incubated
with VSV-GFP virus for 12 h and fluorescence was read at 560 nm. The means +/ SD are shown. This data are representative of at
least two independent repeats. Viruses were isogenic pairs of H5N1 5092 and H9N2 UDL01 with point mutation to knock out functional
full-length PB1-F2 protein (K), blue) or wild-type PB1-F2 coding capacity (WT, red). Mock samples were uninfected cell supernatants.
(d) DF-1 cells were transfected with a chicken IFN-2 promoter firefly luciferase reporter, constitutively active Renilla expression plas-
mid and 2 µg of PB1-F2 overexpression plasmid. Twelve hours post-transfection, cells were re-transfected with 0.25 µg of poly I : C . At
24 h post-transfection, cells were lysed and luciferase activity was quantified. The luciferase intensities were normalized to Renilla
expression. The means of three independent experiments +/ SD and one-way ANOVA analysis was performed. **, P<0.005; NS, not
significant.
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localized compared to H5N1 5092, which may explain this
result.
Cytosolic localization of PB1-F2 provides increased
opportunity to directly interact with IKKb but
reduces PB1-F2 cellular stability
We tested the ability of H5N1 5092 and H9N2 UDL01
PB1-F2 to interact with chicken IKKb using co-immu-
noprecipitation in DF-1 cells (Fig. 5b). Both V5-tagged
H9N2 UDL01 and H5N1 5092 PB1-F2 proteins were
shown to co-precipitate with a FLAG-tagged chicken
IKKb. The pulldown was more efficient with H9N2
UDL01 PB1-F2 than with H5N1 5092 PB1-F2, despite
less H9N2 UDL01 PB1-F2 protein being present in the
input samples (Fig. 5b). We also saw that in DF-1
cells chicken IKKb localized more closely with the
PB1-F2 of H9N2 UDL01 than that of H5N1 5092
(Fig. 5c, d). A general feature of our work with the
Fig. 5. Co-localization of PB1-F2 with the mitochondria reduced interaction with IKKb and antagonism of NFkB activity. (a) DF-1 cells
were transfected with an NFkB-dependent promoter firefly luciferase reporter, constitutively active Renilla expression plasmid and
2µg V5-PB1-F2 overexpression plasmid. 12 h post-transfection cells were stimulated with poly I : C. At 24 h post-transfection cells
were lysed and luciferase activity was quantified. The luciferase intensities were normalized to Renilla expression. The means of three
independent experiments +/ SD and one-way ANOVA analysis was performed. **, P<0.005; NS, not significant. (b) DF1 cells were co-
transfected with V5-PB1-F2 and chicken IKKb-FLAG expression constructs in varying combinations, as shown. The input expression
levels of V5-PB1-F2 and ckIKKb-FLAG plus the resultant co-immunoprecipitation pulled-down proteins on protein G beads by an anti-
FLAG antibody. This image is representative of the experiment, which was performed twice. (c) DF-1 cells were transfected with com-
binations of ckIKK-b-Flag and V5-PB1-F2 expression plasmids. Twelve hours post-transfection cells were fixed and immunostained
with antibodies against FLAG [ckIKK-b (red)] and V5 [PB1-F2 (green)] and stained with DAPI [nucleus (blue)]. (d) Pearson’s correlation
coefficients of ckIKK-b-Flag and V5-PB1-F2 co-localization were calculated. This was performed for at least 15 separate images from
2 independent experiments and displayed graphically. Significance was calculated using Student’s t-test ****, P0.0001.
James et al., Journal of General Virology
9
Downloaded from www.microbiologyresearch.org by
IP:  194.82.50.2
On: Fri, 01 Feb 2019 15:42:45
H9N2 PB1-F2 protein was the instability of the protein
in cells; we required the use of MG132, a well-
described proteasome inhibitor in order to obtain good
visualization in cells and by Western blot. Despite the
PB1-F2 proteins being cloned into the same plasmid
background, with identical promoters and Kozak
sequences, the H5N1 5092 PB1-F2 protein does not
have the same instability seen with H9N2 UDL01 PB1-
F2 (Fig. 6a). We hypothesized that the difference in
cellular location of the two PB1-F2 proteins may result
in different exposure to proteasomal-mediated degrada-
tion, with interaction with MAVS at the mitochondria
somehow shielding the H5N1 5092 PB1-F2 from degra-
dation. To provide a quantified measure of protein sta-
bility in chicken DF-1 cells, we performed a
cycloheximide chase assay and levels of PB1-F2 expres-
sion were determined post-application of cycloheximide
by Western blot. The H9N2 UDL01 PB1-F2 degrades
significantly from the levels detected at the point of
cycloheximide application (time=0) within 30min,
whereas by 8 h post-cycloheximide application, the
H5N1 5092 PB1-F2 is still visible (Fig. 6a-c).
In Fig. 2 we demonstrated that swapping the H5N1
5092 C-terminus (5092:UDL01), or the four amino
acids termed ‘4M’, for those in the H9N2 UDL01
(5092–4M) resulted in a disruption of the mitochon-
drial localization of H5N1 5092, although the reciprocal
mutations swaps did not completely relocalize H9N2
UDL01 PB1-F2 from the diffuse cytoplasmic staining
pattern to the equivalent level of H5N1 5092. We used
the panel of mutant PB1-F2 proteins in the cyclohexi-
mide chase assay and looked at the time point 1 h
after the addition of cycloheximide to transfected DF-1
cells. We found that disrupting the mitochondrial local-
ization (5092:UDL01 and 5092–4M) resulted in a sig-
nificant difference in the stability of the PB1-F2
proteins (Fig. 6b, c).
DISCUSSION
The capacity of IAV to encode a full-length PB1-F2 is con-
served in 93% of all avian host-isolated IAVs, compared to
43 and 48% from human and swine host isolates. We have
previously demonstrated that the presence of a full-length
PB1-F2 in an avian IAV resulted in a longer virus shedding
profile in chickens and increased viral tissue dissemination
in infected birds, and that these outcomes had a cumulative
effect of prolonging the transmission window of the virus
from an infected chicken to a naïve sentinel chicken [6].
The absence of a full-length PB1-F2 also resulted in an
increase in viral pathogenicity in chickens in both our previ-
ous study and that by Leymaire et al. (2014) [6, 11]. PB1-F2
has been described previously to have cell-type-specific and
viral strain-specific activities. Here we show that PB1-F2
proteins from two avian IAVs of the subtypes H5N1 and
H9N2 inhibit the production of type I IFN in chicken cells
and can interact with chicken MAVS upstream of the type 1
interferon promoter (Figs 3 and 4). In addition, these two
PB1-F2 proteins can antagonize NFkB activation and inter-
act with chicken IKKb (Fig. 5). PB1-F2-induced suppres-
sion of type 1 IFN and NFkB must occur in vivo in
chickens, since lower levels of ISG and pro-inflammation
transcripts, which are stimulated by onward signalling from
type 1 IFN induction and NFkB activation, were observed
in nasal tissue from birds that were infected by H9N2 IAV
containing an intact PB1-F2 protein. Specifically, the abun-
dance of transcripts for the ISGs MX, OAS and STAT-1 and
the pro-inflammatory-associated cytokines IL-6 and IL-1b
were all significantly reduced when infection was by a virus
possessing a full-length PB1-F2 protein as compared to
infection by an isogenic virus that did not encode a func-
tional PB1-F2. This suppression of ISGs and pro-inflamma-
tion signals was also observed in a PB1-F2-dependent
manner in vitro in primary chicken fibroblasts and macro-
phages. Some differences in the magnitudes of the transcript
levels were observed between the CEFs and chicken BMDM
upon infection by isogenic viruses that differed only by the
presence of PB1-F2, but this was likely due to different sen-
sitivities of fibroblast and myeloid cells to these induction
signals, since the entry by the viruses at high m.o.i. appeared
to be equal. There was little difference in the magnitude of
apoptosis caused by the individual viruses in the two differ-
ent cell lines as measured using a capsase3/7 activity
reporter (data not shown). Leymarie et al. also report for
another H5N1 influenza isolate that the presence of PB1-F2
suppresses innate responsive transcripts during chicken
infection [11].
There are clear differences in the components of the
type 1 interferon pathway between mammals and
chickens, such as the lack of the pattern recognition
receptor (PRR) RIG-I and transcription factor IRF-3 in
chickens. Instead, the influenza pathogen-associated
molecular pattern is recognized by the ‘RIG-I like
receptor’ MDA5 in chicken cells, which then signals
via chicken MAVS located at the mitochondria to the
transcription factor IRF-7, which induces the type 1
interferon promoter in the nucleus [27]. In this study
we have demonstrated for the first time an interaction
between chicken MAVS, the mitochondrial-located
interferon induction pathway adapter and PB1-F2 of
two avian IAV strains. The interaction of PB1-F2 with
human MAVs has been demonstrated, previously, but
there is only 39% homology at the amino acid level
between chicken and human MAVS [19]. Our co-
immunoprecipitation results suggested that the interac-
tion with chicken MAVS was more efficient with the
PB1-F2 from H5N1 5092 as compared to H9N2
UDL01, although both did display the interaction. In
human 293T cells, Varga et al. showed that PB1-F2 of
the vaccine strain A/PR/8/34 interacted with MAVS at
the mitochondria and this resulted in a decreased
mitochondrial membrane potential and antagonism of
type 1 interferon production [19, 20]. It is likely that a
similar mechanism is the cause of the type 1 interferon
induction antagonism seen in chicken cells by PB1-F2,
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since we can demonstrate that interaction does occur
with chicken MAVS and that greater antagonism is
seen by PB1-F2 proteins that co-localize at the
mitochondria with MAVS, e.g. the H5N1 5092 PB1-F2
protein compared to the H9N2 UDL01 PB1-F2 (Figs 1,
2 and S3).
Fig. 6. Stability of PB1-F2 protein in chicken cells. (a) DF-1 cells were transfected with expression plasmids for H9N2 UDL01 and
H5N1 5092 PB1-F2 V5 tagged proteins. At 24 h post-transfection cycloheximide was applied to the cells and then the cells were lysed
at various time points, as indicated. Lysates were run on western blot and probed for V5 (PB1-F2) and actin as a loading control. (b) A
cycloheximide chase assay was performed on DF-1 cells transfected with various wild-type, C-terminal swap and 4M PB1-F2 mutants,
as indicated. The levels of V5-PB1-F2 at time of cycloheximide addition (0 h) and after 1 h were probed using anti-V5 antibody and actin
as a loading control. (c) Densitometry was performed on the V5-PB1-F2 band of the cycloheximide chase assay for both 0 and 1 h time
points. Signal was normalized for actin and 0 h for each V5-PB1-F2 construct was set to 1. Relative V5- PB1-F2 levels at 1 h post-
cycloheximide addition were calculated and are represented graphically. The average of three independent repeats is displayed and
the standard deviation is indicated by error bars. Significance were calculated using Student’s t-test. ***, P0.0005; ns, not significant.
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Additionally, we have demonstrated interaction between
PB1-F2 and chicken IKKb for the first time. When NFkB is
released from inhibition it translocates into the nucleus and
acts as a transcription factor stimulating the transcription of
innate response genes, and the phosphorylation action of
the serine kinase, IKKb, on Ikb releases NFkB inhibition. It
has been shown previously that PB1-F2 is able to interact
directly with human IKKb [28]. There is an 83% amino
acid conservation between human and the chicken IKKb
homologue. We found that the H9N2 UDL01 PB1-F2 had a
more efficient interaction with IKKb than H5N1 5092. We
hypothesize that interaction with chicken MAVS results in
the inhibition of onward interferon induction pathway sim-
ulation and is likely how PB1-F2 elicits an effect on ISG lev-
els, and similarly, the interaction of PB1-F2 with IKKb may
prevent the phosphorylation of Ikb and thus inhibit the
translocation of NFkB to the nucleus, resulting in the inhi-
bition of pro-inflammation cytokines. The variability in the
strength of the interaction of the avian influenza virus PB1-
F2 proteins with either chicken MAVS or chicken IKKb
corresponded to the potency of the two PB1-F2 proteins to
antagonize type I IFN induction and NFkB activation. More
H5N1 5092 PB1-F2 was precipitated with chicken MAVS
and it also had a greater ability to antagonize the type I IFN
induction pathway as compared to H9N2 UDL01 PB1-F2.
In contrast, H9N2 UDL01 PB1-F2 had a more substantial
interaction with IKKb and was able to antagonize the acti-
vation of an NFkB dependent promoter significantly in
comparison to the H5N1 5092 PB1-F2 protein. The differ-
ences in antagonism potency correlated with the degree of
PB1-F2 localization to the mitochondria. Significant co-
localization with mitochondrial markers, including MAVS,
was associated with enhanced antagonism of type I IFN pro-
duction, but reduced NFkB activation inhibition. Taken
together, this work suggests a mechanism by which PB1-F2
can interact with chicken MAVS and chicken IKK-b to
downregulate type 1 IFN and the downstream pro-inflam-
matory signals in infected cells in vivo, which results in
reduced pathogenicity and impaired viral clearance in
chickens.
Cellular localization was established for a panel of avian
influenza PB1-F2 proteins, which clearly established two
phenotypes: predominantly mitochondrial or predomi-
nantly cytoplasmic (Fig. 1). The two PB1-F2 proteins inves-
tigated here, H5N1 5092 and H9N2 UDL01, were
representative of each group, with H5N1 5092 being prefer-
entially localized to the mitochondria, the location of
chicken MAVS (Fig. S2), and H9N2 UDL01 having a diffuse
cytoplasmic localization that was the same as chicken IKKb
(Fig. 5 c). It has previously been demonstrated that the C-
terminus is responsible for the mitochondrial localization of
PB1-F2 in mammalian cells [23] and indeed when we
swapped the C-terminus portions of the H5N1 5092 for that
of H9N2 UDL01 PB1-F2 proteins we observed a relocaliza-
tion away from the mitochondria to the cytoplasm in
chicken fibroblast cells (Fig. 2). However, a reciprocal swap
only partially retargeted the PB1-F2 to the mitochondria,
with statistical analysis by Student’ s t-test between the Pear-
son’s localization value for H5N1 5092 and UDL01 : 5092
indicating that they were still significantly different (P
value=0.008). This suggests that features in the N-terminus
of the H5N1 5092 PB1-F2 make an additional contribution
to mitochondrial localization. By altering only four amino
acids in the C-terminus of the H5N1 5092 to those found in
the H9N2 UDL01 PB1-F2 protein (Q60R, L62H, S66N and
T68I), producing our 5092–4M mutant, we disrupted the
H5N1 5092 mitochondrial association (Fig. 2 c). A triple
mutant H5N1 5092 PB1-F2 protein (L62H, S66N, T68I)
where residues were changed to those found in the H9N2
UDL01 PB1-F2, as in the 5092–4M mutant, did not result
in significant retargeting of the H5N1 5092 PB1-F2 (data
not shown). Cheng et al. showed that the introduction of
the motif I68, L69, V70 and F71 to H5N1 A/Hong Kong/
156/97 relocated this PB1-F2 to the mitochondria in mam-
malian cells, while replacement of this motif in the PB1-F2
of H1N1 A/Puerto Rico/8/34 removed mitochondria associ-
ation [22]. We found no conservation of this motif in the
PB1-F2 proteins we analysed for cellular localization. Simi-
larly, Chen et al. demonstrated an enhancement of the mito-
chondrial localization of H5N1 A/Hong Kong/156/97 PB1-
F2 when two additional leucine residues (Q69L and H75L)
were introduced in the C-terminus [23]. Our analysis shows
no correlation between the numbers of leucine residues in
the C-terminus of PB1-F2 and whether predominant mito-
chondrial localization occurs in chicken cells (Fig. 2d).
Gibbs et al. postulated the presence of an amphipathic helix
and a short preceding hydrophobic patch in the C-terminus
of PR8 PB1-F2 (aa 65–87) and hypothesized that this was
responsible for the targeting of the protein to the mitochon-
dria [24]. We again found no correspondence between this
area of sequence; all the sequences we analysed, regardless
of observed cellular localization, had a predicted helix struc-
ture and four out of the five basic residues observed in the
PR8 amphipathic helix. The upstream hydrophobic residue
patch was the same between viruses that had different cellu-
lar localization.
PB1-F2 has a short half-life within cells and becomes ubiq-
uitinated on conserved lysine residues in the C-terminus as
a post-translational modification [10]. Kosik et al. demon-
strated that mutation of the C-terminal lysine residues at
positions 73, 78 and 85 to arginines reduced ubiquitination
and increased the stability of PB1-F2 in mammalian cells.
We found that H9N2 UDL01 had one fewer lysine residue
in the C-terminus sequence compared to H5N1 5092
(Fig. 2d), but when the stability of both the H9N2 UDL01
and the H5N1 5092 PB1-F2 proteins and the derived C-ter-
minal-altered mutants in chicken cells was assessed, we
found that cellular localization, not the presence of lysines
in the C-terminal sequence, correlated with protein stability.
H5N1 5092 had a strong co-localization with the mitochon-
dria and was the PB1-F2 protein that was most stable in
chicken DF-1 cells. In contrast, disruption of the H5N1
5092 mitochondrial localization via C-terminal (5092:
UDL01) or four-residue swap (5092–4M) with the H9N2
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UDL01 PB1-F2 resulted in significant degradation of the
PB1-F2 protein by 1 h after the addition of cycloheximide.
We suggest, therefore, that PB1-F2 proteins that are pre-
dominantly targeted to the mitochondria are protected from
ubiquitin-directed proteosomal degradation compared to
PB1-F2 proteins that have a diffuse cytoplasmic localization.
Indeed, studies by others also support this hypothesis;
Cheng et al. demonstrate that the predominantly mitochon-
dria-located PB1-F2 of A/Puerto Rico/8/34 has a signifi-
cantly longer half-life in HeLa cells compared to the PB1-F2
from A/Hong Kong/156/97, which is cytoplasmic in locali-
zation, and this finding has also been observed by Kosik
et al. for the same strains in 293T cells [10, 22]. Chen et al.
showed that a H1N1 A/Taiwan/3355/1997 PB1-F2 that
localized to the mitochondria had the same stability in 293T
cells as the A/Puerto Rico/8/34 PB1-F2 [23]. PB1-F2 has
been shown to have a dramatically differing secondary
structure that is dependent upon the sequence and the envi-
ronment in which the proteins reside [29, 30]. In aqueous
solution, PB1-F2 isdisordered and in the presence of mem-
branes PB!-F2 can form a structured fibre which can disrupt
those membranes [8]. The differing predominant localiza-
tions of the H5N1 5092 and H9N2 UDL01 PB1-F2 viruses
could influence the protein structure in infected cells and
consequently their functionality.
Our results suggest that the PB1-F2 protein can operate at
different points within innate immune signalling pathways
in a strain-specific manner that is reminiscent of the influ-
enza NS-1 protein, and that localization of PB1-F2 in the
cell is a driving factor of the protein’s functionality. PB1-F2
is encoded from the +1 reading frame of the functionally
important RNA-dependent RNA polymerase, PB1. Analyses
indicate that the first two positions in the codon of PB1-F2
vary more than position three, which is in line with
+1 translation frame from PB1, and this contributes to the
high non-synonymous-to-synonymous ratio found for PB1-
F2 proteins [31, 32]. The fact that PB1-F2 proteins with dif-
ferent amino acid sequences can use various mechanisms to
achieve the same innate pathway antagonism indicates that
this function is important, at least in avian cells. Whether
evolution of the other viral proteins overrides selection
towards one mechanism or another is yet to be determined.
METHODS
Ethics statement
All animal work was approved and regulated by the UK
Government Home Office under the project licence PPL 30/
2952. All personnel involved in the procedures were
licensed by the UK Home Office. Euthanasia of chickens
was carried out by intravenous administration of sodium
pentobarbital and confirmed through cervical dislocation.
Cells
Madin–Darby canine kidney (MDCK), 293T and chicken
fibroblast Doug Foster 1 (DF-1) cells were grown in com-
plete media [DMEM (Gibco-Invitrogen, Inc.)]
supplemented with 10% foetal bovine serum (FBS) (Biosera,
Inc.), 1 % penicillin/streptomycin (Sigma-Aldrich) and 1%
non-essential aa (Sigma-Aldrich), and maintained at 37

C
in 5% CO2.
Primary chicken embryo fibroblasts (CEFs) were produced
from 10-day-old Rhode Island Red chicken embryos from
specific-pathogen-free (SPF) hens. Embryos were homoge-
nized and trypsinized with 0.25% trypsin/EDTA solution
(Sigma-Aldrich). The homogenate was resuspended in com-
plete media and passed through a Falcon Cell Strainer
(Fisher) before being seeded onto plates for experimenta-
tion. Influenza infections were conducted in Eagle’s mini-
mum essential medium (EMEM) supplemented with 0.35%
bovine serum albumin (BSA) (Sigma-Aldrich), 1% penicil-
lin/streptomycin and 0.25 µgml 1 TPCK-treated trypsin.
Primary chicken bone marrow-derived macrophage cells
(ckBMDM) were produced from male 3-week-old Rhode
Island Red chickens from a SPF flock. Femurs were
extracted, and the marrow was flushed and liberated with
phosphate-buffered saline (PBS). The cells were homoge-
nized, passed through a Falcon Cell Strainer and then iso-
lated via centrifugation on Histopaque 1083 (Sigma-
Aldrich). The cells were washed and resuspended in Roswell
Park Memorial Institute medium-1640 (RPMI-1640)
medium (Invitrogen) supplemented with 5% FBS and 5%
chicken serum (Pirbright), 2.95 g l 1 TBP (Sigma-Aldrich),
1mM sodium pyruvate (Sigma-Aldrich) and 1% penicillin/
streptomycin, and seeded onto plates for experimentation.
BMDMs were stimulated to differentiate by the addition of
10 ngml 1 of chicken colony-stimulating factor 1 (cCSF-1)
for 5 days (The Roslin Institute). Influenza infections were
conducted in the same media without serum.
Primary chicken kidney cells (CKCs) were produced from
2–3-week-old Rhode Island Red chickens from a SPF flock.
Kidneys were extracted, homogenized and trypsinized with
0.25% trypsin/EDTA solution (Sigma). The homogenate
was washed and resuspended in EMEM (Invitrogen) sup-
plemented with 10% FBS (Sigma), 2.95 g l 1 tryptose phos-
phate broth (TPB) (Sigma), 10mM HEPES (Sigma) and 1
penicillin/streptomycin (Sigma). The homogenate was
passed through a Falcon Cell Strainer (Fisher) and seeded
onto plates for experimentation. Influenza infections were
conducted in the same medium without serum.
Viruses
Recombinant A/chicken/Pakistan/UDL01/08H9N2 virus
(H9N2 UDL01) and a reassortant H5N1 5092 influenza
virus where the NS, NP, PA, PB1 and PB2 viral genetic seg-
ments were from A/Turkey/England/5092/91H5N1 virus
and the HA, NA and M viral genetic segments were from
the vaccine strain A/PR/8/34H1N1 virus, were generated
using reverse genetics. Both H9N2 UDL01 PB1-F2-KO and
H5N1 5091 PB1-F2-KO viruses were generated by the
introduction of a stop codon at aa position 12 in the PB1-F2
reading frame; this was constructed by site-directed muta-
genesis in the PB1 genetic segment prior to reverse genetics
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rescue of virus. Reverse genetics virus rescue was performed
by the transfection of human embryonic kidney (HEK)
293T cells (ATCC) and co-culture in MDCK cells (ATCC)
with the addition of 2 µgml 1 of TPCK-treated trypsin
(Sigma-Aldrich).
Expression plasmids
The open reading frame (ORF) of PB1-F2 from the listed
avian influenza viruses – H5N1 50–92 (A/Turkey/England/
5092/91), H3N8a (A/mallard/Alb/156/2001), H10N7 (A/
duck/Italy/1398/V06), H9N2 UDL01 (A/chicken/Pakistan/
UDL01/08), H8N4 (A/mallard/Alb/194/92), H11N9 (A/
duck/Italy/6103/V07), H3N8b (A/duck/Italy/3139/V06)
and H6N2 (A/duck/Italy/2253/V06) – were cloned into the
eukaryotic expression vector pCAGGs with an N-terminal
V5 tag placed in-frame. H5N1 5092 and H9N2 UDL01
PB1-F2 protein were also cloned in the pCAGGs expression
vector with an in-frame FLAG tag at the N-terminus. These
PB1-F2 expression plasmids, along with a pCAGGs vector
containing eGFP, were used in confocal microscopy and co-
immunoprecipitation experiments. Full-length cDNA
clones of chicken MAVS and chicken IKKb were generated
from DF1 cells treated with chicken IFN (1000Uml 1)
overnight and cloned into the expression plasmid pEF.
pLink2 [33].
Co-localization studies in DF-1 cells
DF-1 cells were grown on coverslips before being trans-
fected with the appropriate expression plasmids. Four hours
post-transfection, 5 µM MG132 (Sigma-Aldrich) was
applied to the cells. At 12 h, post-transfection cells were
fixed in 10% formalin (Sigma-Aldrich) and then permeabi-
lized in 0.1% Triton X-100 (Sigma-Aldrich) in PBS. For
mitochondrial staining, cells were incubated in serum-free
DMEM containing 200 nM of MitoTracker CMX-Ros
(Thermo Fisher) prior to fixation. Nuclei were stained with
0.2 µgml 1 of DAPI (4¢,6-diamidino-2-phenylindole)
(Sigma-Aldrich) in dH2O. Proteins tagged with V5 or
FLAG were stained using a 1 : 1000 dilution of either rabbit
aV5 (GeneTex), mouse anti-V5 (SourceBioScience) or
mouse aFLAG (M2, Sigma) or rabbit anti-FLAG (Gene-
Script), and by using goat anti-mouse IgG (H+L) Alexa
Flour 488 or 568 and goat anti-rabbit IgG (H+L) Alexa
Flour 488 or 568 (Thermo Fisher), as appropriate. Confocal
microscopy images were acquired sequentially using a TCS
SP5 confocal microscope (Leica) and 100 objective lens
using mineral oil immersion and analysed using Leica
Application Suite X (Lecia). The transect analysis was based
on the method described by Horner et al., and different
channels from the same image were overlaid using ImageJ
[National Institutes for Health (NIH)] [34]. Three five-
pixel-wide lines per image were randomly drawn in the
MitoTracker or MAVS channel, transecting the area of
interest. The pixel intensities along the transects were
obtained for both channels of interest and displayed graphi-
cally. The three transects were compared individually using
Pearson’s correlation coefficient and the average coefficient
per image was obtained. The graphical representations of
the averaged Pearson’s R values are for at least 10 separate
images from 2 independent experiments. For nuclear vs
cytoplasmic localizations, multiple images were acquired as
above from random fields. The intensity of straining in the
nuclear vs cytoplasmic proportions was acquired using these
images and Cell Profiler (Broad Institute) according to a
published method [35].
Chicken gene transcript quantification
Nasal tissues were dissected, weighed and added to 700 µl of
TRIzol reagent (Life Technologies). Tissue was homoge-
nized with a 5mm stainless steel bead (Qiagen) for 4min at
Table 2. qPCR and RT-qPCR oligonucleotides [40]
Gene Fwd (5¢ to 3¢) Rev (5¢ to 3¢) Probe (5¢ to 3¢)
IFN-l GGCCTTCCTTACCCAAGTCC CCAGTGCCTCAGTTTCCCAG SYBR Green
OAS AAGAACTGGGACTTGGTGGC CCTTCAGCTCCCAGACTGTG SYBR Green
RSAD-2 GGACAAGGACGAGACAGTTCC TCCCGCCTCCTTAAGCATTG SYBR Green
STAT-1 ACTGCATGCATTGGTGGCCCA GCTGACGAACTTGCTGCAGGC SYBR Green
IFN-1 GACAGCCAACGCCAAGC GTCGCTGCTGTCCAAGCATT (FAM)CTCAACCGGATCCACCGCTACACC(TAMRA)
IFN-2 CCTCCAACACCTCTTCAACATG TGGCGTGCGGTCAAT (FAM)TTAGCAGCCCACACACTCCAAAACACTG
(TAMRA)
IFN-g GTGAAGAAGGTGAAAGATATCA
TGGA
GCTTTGCGCTGGATTCTCA (FAM)TGGCCAAGCTCCCGATGAACGA(TAMRA)
IL-1b GCTCTACATGTCGTGTGTGATGAG TGTCGATGTCCCGCATGA (FAM)CCACACTGCAGCTGGAGGAAGCC(TAMRA)
IL-6 AACATGCGTCAGCTCCTGAAT TCTGCTAGGAACTTCTCCA
TTGAA
(FAM)AGCAGCACCTCCCTCAAGGCACC(TAMRA)
IL-8 GCCCTCCTCCTGGTTTCAG TGGCACCGCAGCTCATT (FAM)TCTTTACCAGCGTCCTACCTTGCGACA(TAMRA)
IL-10 CATGCTGCTGGGCCTGAA CGTCTCCTTGATCTGCTTGATG (FAM)CGACGATGCGGCGCTGTCA(TAMRA)
MX CACTGCAACAAGCAAAGAAGGA TGATCAACCCCACAAGGAAAA (FAM)ACAAAGCACACACCCAACTGTCAGCG(TAMRA)
RDLPO-
1
TTGGGCATCACCACAAAGATT CCCACTTGTCTCCGGTCTTAA (FAM)CATCACTCAGAATTTCAATGGTCCCTCGGG
(TAMRA)
RPL13 TCGTGCTGGCAGGATTC TCGTCCGAGCAAACCTTTTG (FAM)TAATGCCCGCCAGTTTAAGCTCTTCTAGGC
(TAMRA)
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20Hz using a TissueLyser II (Qiagen). RNA was then
extracted from centrifuge-clarified homogenate via chloro-
form and ethanol precipitation. RNA was isolated from cells
using a silica-membrane-based RNeasy Mini kit (Qiagen)
according to the manufacturer’s instructions. Genomic
DNA was eliminated using RNase-Free DNase On-Column
Digestion (Qiagen). For subsequent analysis of host tran-
scripts by RT-qPCR, cDNA synthesis was performed using
Random Primers (Thermo Fisher) and SuperScript III
Reverse Transcriptase (Invitrogen). All quantitative PCR
(qPCR) was performed using a 7500 Fast and Real-Time
PCR System (Applied Biosystems). Twentymicrolitres of
either TaqMan Universal PCR Master Mix or Power SYBR
Green Master Mix were used with 2 µl of cDNA according
to the manufacturer’s instructions with the primer and
probe sets defined in Table 2. Gene expression data were
normalized against a stable reference gene and compared
against the mock controls using the 2-DDCt method [36].
Reference genes (RDPLO-1 and RSAD) were selected from
previous data using GeNorm Reference Gene Selection soft-
ware (GeNorm) analysis of multiple reference genes on
independent samples under identical conditions (White-
head et al., 2017 under review).
Viral RNA quantification
Quantification of vRNA was performed as previously
described [6]. SuperScript III One-Stepreverse tran-
scription-PCR (RT-PCR)system with Platinum Taq DNA
Polymerase kit (Invitrogen) was usedaccording to the man-
ufacturer’s instructions ona 7500 Fast and Real-Time PCR
System (Applied Biosystems). Primers and a Taqman probe,
specific for a conserved region of the influenza A matrix
gene were used as previously published [37] (Spackman
et al., 2002). The cycling conditions were: 50

C for 5min,
95

C for 2min and then 40 cycles of 95

C for 3 s and 60

C
for 30 s. A T7-transcribed RNA standard of the M gene
from A/PR 8/34 (H1N1) was included in each assay to gen-
erate a standard curve. Ct values were extrapolated against
this curve and the results were expressed as copy numbers
of the influenza M gene.
Co-immunoprecipitation of PB1-F2 and ck MAVs or
ck IKKb
Chicken MAVS-V5 or IKKb-FLAG expression plasmids
were co-transfected into DF-1 cells along with PB1-F2 con-
taining a FLAG or V5 tag as appropriate, using lipofect-
amine 2000 according to the manufacturer’s instructions.
After incubation for 24 h after transfection, cells were lysed
in Pierce Immuoprecipitation Lysis Buffer (Thermo Fisher)
and then processed immediately. The lysates were pre-
cleared by adding 0.5mgml 1 of Pierce Protein G Magnetic
Beads (Thermo Fisher) and a 12-tube magnetic rack (Qia-
gen). The samples were incubated overnight at 4

C with
10 µgml 1 of primary antibody [mouse anti-FLAG (Sigma
M2)] or rabbit anti-V5 antibody (Genetex) and then incu-
bated at 4

C for 6 h with 0.5mgml 1 of magnetic beads.
The beads were magnetically isolated and washed three
times in Pierce Immuoprecipitation Lysis Buffer (Thermo
Fisher). The beads were then boiled in SDS-loading dye for
10min and used for Western blot analysis.
VSV-GFP interferon bioassay
The supernatants from three independent experiments
involving cells infected with each indicated influenza virus
at an m.o.i. of 3 were heated at 60

C for 30min to inactivate
influenza virus. This was confirmed by performing an in-
cell enzyme-linked immunosorbent assay (ELISA) for influ-
enza nucleoprotein. In technical triplicate, the supernatants
were twofold serially diluted in complete media on DF-1
cells (4104 cells well 1) in a 96-well opaque white plate
(Pierce) and incubated for 12 h. Cells were infected with
GFP-tagged vesicular stomatitis virus (VSV-GFP) [38] at an
m.o.i. of 3 in Opti-MEM with no phenol red (Thermo).
Then, 12 h post-infection, the medium was removed and
GFP fluorescence was measured using a GloMax multi-plate
reader fluorescence module (Promega). SF9-produced
chicken interferon-b was used as a positive control (The
Pirbright Institute). No VSV-GFP virus was used to estab-
lish background fluorescence and media-only incubations
were used to establish maximum fluorescence. The percent-
age antiviral effect was then calculated using the following
formula and displayed graphically:
% antiviral effect¼
sample fluor   background fluorð Þ  100
max fluor  background fluor
  100
Luciferase reporter assays
For assaying interferon modulation, a pGL3 luciferase (luc)
reporter vector containing the promoter regions from
chicken IFN-2 upstream of a firefly luc gene was used. For
assaying NF-kB activity, a similar reporter vector was used
containing six tandem repeats of the NF-kB consensus
binding sequence (5¢-GGGACTTTCC-3¢) upstream of a
thymidine kinase (TK) minimal promoter. In triplicate, cells
were transfected accordingly with 100 ng of Renilla luc
pCAGGs expression plasmid, 500 ng chIFN-2-, chMX- or
NF-kB luciferase reporter plasmids and 2 µg PB1-F2 protein
expression plasmids. For assays involving polyinosinic : pol-
ycytidylic acid [poly (I : C)] stimulation, 6 h post-transfec-
tion cells were retransfected with 0.25 µg poly I : C (Sigma).
After the experimental time point was reached, cells were
lysed and read using the Stop and Glo reagents (Promega).
Each individual firefly and Renilla value was checked for
consistency, and then the firefly luciferase signals were nor-
malized to Renilla signals.
Cycloheximide chase assay
DF1s were transfected with 250 ng ul 1 of the appropriate
V5-PB1-F2 or GFP plasmid. Twenty-four hours post-trans-
fection, cells were treated with 100 ugml 1 cycloheximide
(Sigma). Samples were collected at appropriate time points
by washing with PBS and lysing with Laemmli buffer. Sam-
ples were visualized on Western blots using mouse anti-V5
antibody (abcam) and IRDye donkey anti-mouse (800 nm)
(LiCor). Actin was used as a loading control and visualized
using mouse anti-actin antibody (abcam) with IRDye
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donkey anti-mouse (800 nm) (LiCor). GFP was used as a
stable protein control. Bands were quantified using ImageJ
(NIH) and PB1-F2 was normalized to the actin loading
control.
Viral polymerase activity assay
In triplicate, DF-1 cells were transfected with 20 ng of PA,
160 ng of NP, and 80 ng of each of the PB1 and PB2
pCAGGs expression plasmids. Transfection reactions also
included 250 ng of chicken-specific viral RNA-dependent
RNA polymerase firefly luciferase reporter (described previ-
ously [39]) and 100 ng of a Renilla luciferase pCAGGs
expression plasmid. Cells were incubated for 24 h at either
37 or 41

C before being lysed in 100 µl of 1 passive lysis
buffer (Promega). Plates were frozen for 30min at  80 C
and defrosted before reading. Then 10 µl of lysate was
loaded onto a 96-well opaque white plate (Pierce) and ana-
lysed on a GloMax multi-plate reader (Promega) with 50 µl
of LARII and Stop and Glo reagents (Promega). Each indi-
vidual firefly and Renilla value was checked for consistency,
and then the firefly luciferase signals were normalized to
Renilla signals.
Viral growth curves
In triplicate, in six-well plates, chicken kidney cells were
infected with a virus m.o.i. of 0.0001 1 h at 37

C. The cells
were washed with PBS and incubated at 37

C with 2ml of
appropriate media containing no serum. Then 500 µl of
supernatant was taken at the indicated time points after
infection and replenished, and the samples were stored at
 80 C. All samples were titrated via plaque assay on
MDCK cells including the input.
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